home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Busting Up Gallstones

 
  November, 23 2004 8:41
your information resource in human molecular genetics
 
     
A compound that alters the composition of the digestive fluid bile might prevent gallstone formation, according to a report in the December issue of Nature Medicine.

Cholesterol gallstone disease occurs when cholesterol builds up in bile, the digestive substance made in the liver and stored in the gallbladder. Previous work had suggested that the gene regulator FXR (farnesoid X receptor) can control the amount of cholesterol in the bile. David Mangelsdorf and colleagues found that mice lacking FXR are prone to developing gallstones. What's more, a compound that activates FXR keeps cholesterol levels low and prevents gallstone formation. The compound could provide an alternative to surgery to removing the gallbladder, a common treatment when gallstones become lodged in the bile duct and become painful.

Author contact:

David Mangelsdorf (University of Texas Southwestern Medical Center, Dallas, TX, US)
Tel: + 1 214 648 6349, E-mail: Davo.Mango@UTSouthwestern.edu

Also available online.

(C) Nature Medicine press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.